In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown. On demand presentation Register free
Register Free: http://www.appliedclinicaltrialsonline.com/act_w/patient_experience
Event Overview:
The COVID-19 pandemic brought most of the world to standstill, with quarantine making it difficult for physicians and patients to start new research programs within their practice or to restart their existing studies. As more healthcare practices open to provide care for their patients, what considerations need to be made to make sure healthcare workers and patients can access their treatments in a safe environment while keeping research programs compliant without compromising study quality or data integrity?
In this presentation, Elligo offers an overview of steps to reopen sites, both for those working on restarting existing programs and those looking to start new ones, by utilizing patient and principal investigator feedback from existing sites, using tech-enabled solutions and developing standard operating procedures to instill new best practices post-COVID-19 lockdown.
Key Learning Objectives:
Operational considerations and innovations for:
Speakers: Faith Holmes, M.D., Medical Director, Elligo
Jacylyn Bodmer, Chief Information & Technology Officer, Elligo
Time and Date: On demand presentation
Sponsor: Elligo
Register Free: http://www.appliedclinicaltrialsonline.com/act_w/patient_experience